Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838. Case and Commentary Feb 2020 How Should Physicians in Low- and Middle-Income Countries Regard Electronic Nicotine Delivery Systems to Facilitate Smoking Cessation? Thomas E. Novotny, MD, MPH, DSc (Hon) and May C. I. van Schalkwyk, MBBS, MPH Vaping has been thought to be a safe, effective smoking cessation aid, but little evidence supports its value in mitigating tobacco use. AMA J Ethics. 2020;22(2):E82-92. doi: 10.1001/amajethics.2020.82. Case and Commentary Dec 2008 Shared Decision Making: Physicians’ Duties to Patients and Other Physicians Dawn Brezina, MD Having implied that a particular clinical decision had been made to “free up a hospital bed,” the attending physician walked away without further comments to the residents or talking with the patient. Virtual Mentor. 2008;10(12):784-787. doi: 10.1001/virtualmentor.2008.10.12.ccas1-0812. Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302. Case and Commentary Nov 2003 "Concierge" Practice and the Profession's Contract with Society Troy Brennan, MD, JD, MPH Virtual Mentor. 2003;5(11):496-498. doi: 10.1001/virtualmentor.2003.5.11.ccas3-0311. Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 1 Robert Goodman, MD Virtual Mentor. 2003;5(7):239-241. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838.
Case and Commentary Feb 2020 How Should Physicians in Low- and Middle-Income Countries Regard Electronic Nicotine Delivery Systems to Facilitate Smoking Cessation? Thomas E. Novotny, MD, MPH, DSc (Hon) and May C. I. van Schalkwyk, MBBS, MPH Vaping has been thought to be a safe, effective smoking cessation aid, but little evidence supports its value in mitigating tobacco use. AMA J Ethics. 2020;22(2):E82-92. doi: 10.1001/amajethics.2020.82.
Case and Commentary Dec 2008 Shared Decision Making: Physicians’ Duties to Patients and Other Physicians Dawn Brezina, MD Having implied that a particular clinical decision had been made to “free up a hospital bed,” the attending physician walked away without further comments to the residents or talking with the patient. Virtual Mentor. 2008;10(12):784-787. doi: 10.1001/virtualmentor.2008.10.12.ccas1-0812.
Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302.
Case and Commentary Nov 2003 "Concierge" Practice and the Profession's Contract with Society Troy Brennan, MD, JD, MPH Virtual Mentor. 2003;5(11):496-498. doi: 10.1001/virtualmentor.2003.5.11.ccas3-0311.
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 1 Robert Goodman, MD Virtual Mentor. 2003;5(7):239-241. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205.